Medasense Biometrics LTD, based in Ramat Gan, is revolutionizing the assessment and treatment of pain worldwide. Using their cutting-edge AI technology and sensing platform called Confident Pain Management, Medasense is transforming the way pain is understood and managed. Their flagship product, PMD-200™, is utilized in critical care settings to visualize pain response and personalize treatment, providing valuable insights to healthcare professionals.

Medasense also has a pipeline of products that utilize their AI capabilities to predict, stratify, and prevent pain. Through their breakthrough NOL® AI technology and sensor platform, Medasense quantifies pain response, optimizing patient care and helping to avoid overmedication. Clinical studies have shown the impact that NOL monitoring has on patient safety and outcomes, including a 33% reduction in reported postoperative pain.

Medasense offers comprehensive clinical resources, including educational materials, simulation hubs, clinical guides, and lectures. With a global network of distribution, Medasense is at the forefront of transforming pain management and improving the lives of millions worldwide